Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTX Discontinuation and Influenza Vaccine Efficacy in RA
NCT02748785Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ARCT-2138 in influenza, sponsored by Seoul National University Hospital. Started Sep 2015; status: completed.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02748785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748785.